183 related articles for article (PubMed ID: 24510673)
1. Protein O-mannosylation in metazoan organisms.
Panin VM; Wells L
Curr Protoc Protein Sci; 2014 Feb; 75():12.12.1-12.12.29. PubMed ID: 24510673
[TBL] [Abstract][Full Text] [Related]
2. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.
Nakamura N; Lyalin D; Panin VM
Semin Cell Dev Biol; 2010 Aug; 21(6):622-30. PubMed ID: 20362685
[TBL] [Abstract][Full Text] [Related]
3. Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted.
Nakamura N; Stalnaker SH; Lyalin D; Lavrova O; Wells L; Panin VM
Glycobiology; 2010 Mar; 20(3):381-94. PubMed ID: 19969597
[TBL] [Abstract][Full Text] [Related]
4. Glycomic analyses of mouse models of congenital muscular dystrophy.
Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.
Live D; Wells L; Boons GJ
Chembiochem; 2013 Dec; 14(18):2392-402. PubMed ID: 24318691
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in understanding mammalian O-mannosylation.
Sheikh MO; Halmo SM; Wells L
Glycobiology; 2017 Sep; 27(9):806-819. PubMed ID: 28810660
[TBL] [Abstract][Full Text] [Related]
7. O-Mannosylation and human disease.
Dobson CM; Hempel SJ; Stalnaker SH; Stuart R; Wells L
Cell Mol Life Sci; 2013 Aug; 70(16):2849-57. PubMed ID: 23115008
[TBL] [Abstract][Full Text] [Related]
8. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.
Stalnaker SH; Hashmi S; Lim JM; Aoki K; Porterfield M; Gutierrez-Sanchez G; Wheeler J; Ervasti JM; Bergmann C; Tiemeyer M; Wells L
J Biol Chem; 2010 Aug; 285(32):24882-91. PubMed ID: 20507986
[TBL] [Abstract][Full Text] [Related]
9. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
11. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
13. The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.
Wells L
J Biol Chem; 2013 Mar; 288(10):6930-5. PubMed ID: 23329833
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
16. Protein O-mannosylation across kingdoms and related diseases: From glycobiology to glycopathology.
Hang J; Wang J; Lu M; Xue Y; Qiao J; Tao L
Biomed Pharmacother; 2022 Apr; 148():112685. PubMed ID: 35149389
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.
Lefeber DJ; Schönberger J; Morava E; Guillard M; Huyben KM; Verrijp K; Grafakou O; Evangeliou A; Preijers FW; Manta P; Yildiz J; Grünewald S; Spilioti M; van den Elzen C; Klein D; Hess D; Ashida H; Hofsteenge J; Maeda Y; van den Heuvel L; Lammens M; Lehle L; Wevers RA
Am J Hum Genet; 2009 Jul; 85(1):76-86. PubMed ID: 19576565
[TBL] [Abstract][Full Text] [Related]
18. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of β-1,4-N-acetylglucosaminyltransferase 2: structural basis for inherited muscular dystrophies.
Yang JY; Halmo SM; Praissman J; Chapla D; Singh D; Wells L; Moremen KW; Lanzilotta WN
Acta Crystallogr D Struct Biol; 2021 Apr; 77(Pt 4):486-495. PubMed ID: 33825709
[TBL] [Abstract][Full Text] [Related]
20. Protein
Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L
J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
